Matinas BioPharma names chief development officer
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Matinas BioPharma Holdings Inc., a Bedminster, N.J.-based biopharmaceutical company, appointed Theresa Matkovits as its chief development officer.
Matkovits most recently served as the COO of ContraVir Pharmaceuticals Inc., a biopharmaceutical company focusing on the development of antiviral drugs.
